Director dealings: Haleon CFO sells shares

(Sharecast News) - Haleon revealed on Wednesday that chief financial officer Dawn Allen had disposed of 83,894 ordinary shares in the London-listed consumer healthcare company. Allen, who made the sale in two separate transactions, offloaded the shares at an average price of 375.64p each, for a total value of £315,137.75p.

As of 1540 BST, Haleon shares were down 0.53% at 373.60p.



Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Faron Pharmaceuticals Oy (di) (FARN) Director name: Pätsi,Tuomo Amount purchased: 21,500 @ 2.43 Value: 47,164.41

Triad Group (TRD) Director name: Lander,Alison Amount purchased: 6,722 @ 297.50p Value: £19,997.95

Utilico Emerging Markets Ltd (di) (UEM) Director name: Wells ,Nadya Amount purchased: 3,290 @ 244.00p Value: £8,027.60

Stelrad Group (SRAD) Director name: Ker,Katherine Innes Amount purchased: 2,515 @ 163.00p Value: £4,099.45

Top Director Sells

Haleon (HLN) Director name: Allen,Dawn Amount sold: 64,329 @ 375.64p Value: £241,644.17

Haleon (HLN) Director name: Allen,Dawn Amount sold: 19,565 @ 375.64p Value: £73,493.58

Rs Group (RS1) Director name: Ringrose ,Kate Amount sold: 6,143 @ 580.50p Value: £35,660.11